Recent clinical trials like ADRIATIC and IMforte are shaping the future of small cell lung cancer (SCLC) treatment, explained Angel Qin, MD. She also emphasized the growing role of immunotherapy in ...
The FDA has granted approval to pembrolizumab for the treatment of adult patients with resectable, locally advanced HNSCC whose tumors express PD-L1 with a CPS of ≥1. IO Biotech's first-in-class ...
Anant Madabhushi, director of the Center for Computational Imaging and Personalized Diagnostics, had a presentation featured at the Immuno-Oncology 360° conference. His talk, titled “Applying a Novel ...
SANTA ANA, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization ...
Sportschosun on MSN
Liver cancer immune cancer treatment effect, predicted by a drop of blood...Development of a New Bio...
A new blood test method has been published in an international journal to predict the response to immune cancer treatment in advanced liver cancer patients.Liver cancer, which ranks third in terms of ...
The new venture is backed by Biovance Capital, Torrey Pines Investment, and OrbiMed. Mondego Bio is advancing a portfolio of first- and best-in-class PTPN2 inhibitors designed to transform cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback